Ran Nussbaum

Insider Reports History

Entity
Individual
Location
C/O Kite Pharma, Inc., 2225 Colorado Avenue, Santa Monica, CA
Signature
/s/ Keith Regnante, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ran Nussbaum:

Stock Role Class Num Shares Value Price $ Report Date Ownership
UroGen Pharma Ltd. Director Ordinary Shares 1.49M $26.7M $18.01 Oct 21, 2022 Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd
Eloxx Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 20K Jun 15, 2022 Direct
Keros Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 10K May 30, 2024 Direct
UroGen Pharma Ltd. Director Stock Option (right to buy) 0 Oct 21, 2022 By Pontifax Cayman III Limited Partnership
UroGen Pharma Ltd. Director Stock Option (right to buy) 0 Oct 21, 2022 By Pontifax (Israel) III Limited Partnership

Insider Reports Filed by Ran Nussbaum

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KROS Keros Therapeutics, Inc. May 30, 2024 1 $0 4 Jun 3, 2024 Director, 10%+ Owner
KROS Keros Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director, 10%+ Owner
KROS Keros Therapeutics, Inc. Nov 29, 2022 6 -$1 4 Nov 30, 2022 Director, 10%+ Owner
URGN UroGen Pharma Ltd. Oct 21, 2022 3 $285K 4/A Feb 28, 2023 Director
URGN UroGen Pharma Ltd. Jun 16, 2022 2 $11.1K 4 Feb 28, 2023 Director
ELOX Eloxx Pharmaceuticals, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
URGN UroGen Pharma Ltd. Jun 8, 2022 2 $0 4 Jun 10, 2022 Director
URGN UroGen Pharma Ltd. Jun 6, 2022 2 $5.15K 4/A Feb 28, 2023 Director
KROS Keros Therapeutics, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director, 10%+ Owner
KROS Keros Therapeutics, Inc. Jun 1, 2021 1 $0 4 Jun 3, 2021 Director, 10%+ Owner
ELOX Eloxx Pharmaceuticals, Inc. May 19, 2021 1 $0 4 May 20, 2021 Director
ELOX Eloxx Pharmaceuticals, Inc. May 13, 2021 4 $8M 4 May 17, 2021 Director
URGN UroGen Pharma Ltd. Mar 25, 2021 2 $5.15K 4/A Jun 9, 2021 Director
URGN UroGen Pharma Ltd. Mar 25, 2021 4 $11.1K 4 Jun 9, 2021 Director
KROS Keros Therapeutics, Inc. Apr 7, 2020 0 $0 3/A Nov 30, 2022 Director, 10%+ Owner